Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

UFP Technologies, Inc. - Common Stock (NQ:UFPT)

197.01 -16.59 (-7.77%)
Streaming Delayed Price Updated: 1:28 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about UFP Technologies, Inc. - Common Stock

< Previous 1 2 3 Next >
UFP Technologies (UFPT) Q2 EPS Jumps 27%
Via The Motley Fool
UFP Technologies (UFPT) Shares Skyrocket, What You Need To Know
Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 11.9% in the afternoon session after the company posted record second-quarter results and beat analyst profit expectations. The... 
Via StockStory
Topics ETFs Stocks World Trade
UFP TECHNOLOGIES INC (NASDAQ:UFPT) Reports Record Q2 2025 Earnings with EPS Beat but Revenue Miss
UFP Technologies reports record Q2 2025 earnings, beating EPS estimates but slightly missing revenue. Shares dip 1% amid mixed market reaction. Strong YoY growth in medical device demand. 
Via Chartmill
UFP Technologies (NASDAQ:UFPT) Posts Q2 Sales In Line With Estimates
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 37.2% year on year to $151.2 million. Its non-GAAP profit of $2.50 per share... 
Via StockStory
Earnings Scheduled For August 4, 2025
 
Via Benzinga
What to Expect from UFP Techs's Earnings
 
Via Benzinga
An Overview of UFP Techs's Earnings
 
Via Benzinga
UFP Technologies (UFPT) To Report Earnings Tomorrow: Here Is What To Expect
Medical products company UFP Technologies (NASDAQ:UFPT) will be announcing earnings results this Monday after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
1 Small-Cap Stock Worth Your Attention and 2 Facing Headwinds
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Topics Emissions
10 Growth Stocks Down 10% or More to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence Fraud World Trade
1 Volatile Stock with Exciting Potential and 2 to Question
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned... 
Via StockStory
Topics ETFs Stocks World Trade
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. 
Via StockStory
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life sciences tools & services stocks,... 
Via StockStory
Topics Artificial Intelligence
1 Profitable Stock with Competitive Advantages and 2 to Think Twice About
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how UFP Technologies (NASDAQ:UFPT)... 
Via StockStory
3 Hyped Up Stocks Facing Headwinds
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
UFPT Q1 Earnings Call: Medical Segment Growth and Strategic Expansion Drive Outperformance
Medical products company UFP Technologies (NASDAQ:UFPT) announced better-than-expected revenue in Q1 CY2025, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of $2.47 per share... 
Via StockStory
UFP Technologies (NASDAQ:UFPT) Reports Upbeat Q1, Stock Soars
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of... 
Via StockStory
UFP Technologies (UFPT) Q1 Earnings Report Preview: What To Look For
Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting earnings tomorrow before market hours. Here’s what to look for. 
Via StockStory
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Why quality investors should have a look at UFP TECHNOLOGIES INC (NASDAQ:UFPT).
A fundamental analysis of (NASDAQ:UFPT): Should you consider UFP TECHNOLOGIES INC (NASDAQ:UFPT) for quality investing? 
Via Chartmill
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest... 
Via StockStory
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. 
Via StockStory
1 Healthcare Stock on Our Watchlist and 2 to Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
3 Small-Cap Stocks Walking a Fine Line
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Azenta (NASDAQ:AZTA) and its peers. 
Via StockStory
What To Expect From Fortrea’s (FTRE) Q4 Earnings
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what investors should know. 
Via StockStory
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.